Sir Greg Winter
|Born||14 April 1951|
|Education||Royal Grammar School, Newcastle upon Tyne|
|Alma mater||University of Cambridge (MA, PhD)|
|Thesis||The amino acid sequence of tryptophanyl tRNA synthetase from Bacillus stearothermophilus (1977)|
Sir Gregory Paul Winter biochemist. He is best known for his work on the therapeutic use of monoclonal antibodies. He invented techniques to both humanise (1986) and, later, to fully humanise using phage display, antibodies for therapeutic uses.(born 14 April 1951) is a British
References[change | change source]
- WINTER, Sir Gregory (Paul). ukwhoswho.com. Who's Who. Vol. 2016 (online Oxford University Press ed.). A & C Black, an imprint of Bloomsbury Publishing plc. (subscription required)
- "EMBO MEMBER: Gregory P. Winter". people.embo.org.
- "Announcement of the Prince Mahidol Award 2016". princemahidolaward.org. Archived from the original on 2017-11-14. Retrieved 13 June 2017.
- "Nobel Prize in Chemistry 2018 - live". The Guardian. 3 October 2018. Retrieved 3 October 2018.
- McCafferty, J.; Griffiths, A.; Winter, G.; Chiswell, D. (1990). "Phage antibodies: filamentous phage displaying antibody variable domains". Nature. 348 (6301): 552–554. Bibcode:1990Natur.348..552M. doi:10.1038/348552a0. PMID 2247164. S2CID 4258014.
- "Live blog: direction evolution takes chemistry Nobel prize". Retrieved 3 October 2018.